Welcome to LookChem.com Sign In|Join Free
  • or
3,5-bis(1,1-dimethylethyl)-4-hydroxybenzamide, also known as 3,5-Di-tert-butyl-4-hydroxybenzamide, is an organic compound with a unique structure featuring two tert-butyl groups attached to the 3,5 positions of a hydroxybenzene ring and an amide group at the 4 position. 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzamide exhibits specific chemical properties that make it suitable for various applications in different industries.

60632-18-0

Post Buying Request

60632-18-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

60632-18-0 Usage

Uses

Used in Pharmaceutical Industry:
3,5-bis(1,1-dimethylethyl)-4-hydroxybenzamide is used as a key intermediate in the synthesis of 2-(3,5-di-tert-butyl-4-hydroxyphenyl)oxazoles, which are anti-atherosclerotic agents. These agents are designed to combat atherosclerosis, a condition characterized by the hardening and narrowing of arteries, which can lead to heart disease and stroke.
In the preparation of these oxazoles, 3,5-Di-tert-butyl-4-hydroxybenzamide serves as a starting material, undergoing a series of chemical reactions to form the final product. The presence of the tert-butyl groups and the hydroxyl group in the molecule contributes to the stability and activity of the resulting anti-atherosclerotic agents, making them more effective in treating atherosclerosis and its associated complications.

Check Digit Verification of cas no

The CAS Registry Mumber 60632-18-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,0,6,3 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 60632-18:
(7*6)+(6*0)+(5*6)+(4*3)+(3*2)+(2*1)+(1*8)=100
100 % 10 = 0
So 60632-18-0 is a valid CAS Registry Number.

60632-18-0Relevant academic research and scientific papers

2-ARYLTHIAZOLE DERIVATIVES AS CXCR3 RECEPTOR MODULATORS

-

Page/Page column 75, (2010/11/28)

The invention encompasses compounds of Formula I or pharmaceutically acceptable salts thereof, which are modulators of the CXCR3 chemokine receptor function useful for the treatment or prevention of pathogenic inflammatory processes, autoimmune diseases or graft rejection processes. Methods of use and pharmaceutical compositions are also encompassed.

NOVEL COMPOUNDS USEFUL AS NEURO-PROTECTIVE AGENTS

-

, (2008/06/13)

This invention relates to novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents.

Compounds useful as neuro-protective agents

-

, (2008/06/13)

This invention relates to novel phenyl oxazoles, thiazoles, oxazolines, oxadiazoles and benzoxazoles useful as neuro-protective agents.

Method for treating pain

-

, (2008/06/13)

The present invention provides a method for treating pain using a composition comprising certain phenyl oxazoles or phenyl thiazoles in combination with a Drug Useful in the Treatment of Pain.

Method for treating neuropathic pain

-

, (2008/06/13)

The present invention provides a method for treating neuropathic pain comprising administering an analgesic dosage of a compound of formula I to an animal in need of such treatment certain phenyl oxazoles or phenyl thiazoles.

Use of phenyl oxazole or phenyl thiazole derivatives for treating neuropathic pain

-

, (2008/06/13)

The present invention provides a method for treating neuropathic pain comprising administering an analgesic dosage of a compound of formula I to an animal in need of such treatment certain phenyl oxazoles or phenyl thiazoles.

Method for treating pain

-

, (2008/06/13)

The present invention provides a method for treating pain using a composition comprising certain phenyl oxazoles or phenyl thiazoles in combination with a Drug Useful in the Treatment of Pain.

Use of phenyl oxazole or phenyl thiazole derivatives for treating pain

-

, (2008/06/13)

The present invention provides a method for treating pain comprising administering to an animal in need of such treatment, an analgesic dosage of certain phenyl oxazoles or phenyl thiazoles.

Crystal Engineering and Substituent Effect of Hindered Phenols for SHG Materials

Takagi, Koichi,Mizuno, Akira,Kubata, Michiru,Mizoguchi, Akira,Furushow, Masaru,Matsuoka, Masaru

, p. 1743 - 1746 (2007/10/02)

2,6-di-tert-butylphenol moiety was found to be effective to control molecular packing in crystals for SHG materials.Many derivatives having compact acceptor group at 4-position of hindered phenols showed SHG responses depending on the electron withdrawing effect of an acceptor.The X-ray structural analyses revealed that molecular packing was controlled both by the steric requirements and the intermolecular hydrogen bonding.

Alkylamides of hindered 3,5-dialkyl-4-hydroxybenzoic acids and use as light stabilizers in polyolefins

-

, (2008/06/13)

Compounds of the formula: SPC1 Wherein R1 and R2 are each branch-chain alkyl of 3 to 8 carbon atoms and R3 and R4 are each hydrogen, alkyl of 1 to 18 carbon atoms, or cycloalkyl of 5 or 6 carbon atoms are useful as light stabilizers in polyolefins. They may be prepared (a) by reacting the 3,5-di-alkyl-4-hydroxybenzoyl chloride with the appropriate amine in the presence of an acid acceptor or (b) by reacting the corresponding benzoic acid with the appropriate amine in the presence of a carbodiimide as dehydrating agent.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 60632-18-0